HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leila Mendonça-Lima Selected Research

Leila Mendonça-Lima Research Topics

Disease

6Chagas Disease (American Trypanosomiasis)
01/2018 - 10/2005
5Tuberculosis (Tuberculoses)
01/2021 - 04/2011
4Infections
05/2016 - 10/2005
1Communicable Diseases (Infectious Diseases)
01/2018
1Cardiomyopathies (Cardiomyopathy)
01/2012
1Leprosy (Hansen's Disease)
03/2010
1Inflammation (Inflammations)
03/2010
1Drug-Related Side Effects and Adverse Reactions
01/2010
1Neoplasms (Cancer)
01/2010
1Parasitic Diseases (Parasitic Disease)
08/2007
1Leishmaniasis
07/2007

Drug/Important Bio-Agent (IBA)

5VaccinesIBA
01/2021 - 04/2011
5Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2012
3CytokinesIBA
01/2018 - 10/2005
3Transforming Growth Factor beta (TGF-beta)IBA
01/2012 - 10/2005
2EnzymesIBA
01/2020 - 01/2010
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018
1Codon (Codons)IBA
01/2018
1CollagenIBA
05/2016
1Fibronectins (Fibronectin)IBA
05/2016
1cruzipainIBA
01/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2012
1InterleukinsIBA
03/2012
1Virulence Factors (Pathogenicity Factors)IBA
03/2012
1ArginaseIBA
03/2012
1AntibodiesIBA
03/2012
1Leishmania amazonensis kinetoplastid membrane protein-11IBA
03/2012
1Cadherins (E-Cadherin)IBA
05/2011
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
03/2010
1Matrix Metalloproteinases (MMPs)IBA
03/2010
1GelatinasesIBA
03/2010
14- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA
08/2007

Therapy/Procedure

1Therapeutics
07/2007